U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802861) titled 'Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia' on Jan. 24.
Brief Summary: This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia. Further, we will add an exploratory outcome to evaluate the neonatal body composition and anthropometric data to better understand neonatal impacts of maternal metabolic dysfunction.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Preeclampsia
Preeclampsia (PE)
Preeclampsia (PE) Risk
Obesity and Obesi...